Insulet Corporation
PODD Healthcare Medical Devices
Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024. In the quarter to June 2026, revenue grew 23.5%, EPS grew 328.1%, free cash flow fell 70.5% and total debt fell 32.2%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow PODD
Insulet Corporation (PODD) Debt to equity
Insulet Corporation's debt to equity at the end of the quarter to 30 June 2026 was 0.7×, up 0.0× from fiscal 2025 (0.6×). Over the past ten years it has ranged from 0.6× (fiscal 2025) to 11.8× (fiscal 2019) — the current reading is the lowest in ten years. That is above the Medical Devices industry median of 0.1× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Embed this chart
Annual newest first
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | 0.6× | (44.99%) |
| FY2024 | 1.1× | (41.06%) |
| FY2023 | 1.9× | (34.33%) |
| FY2022 | 2.9× | 28.49% |
| FY2021 | 2.3× | 30.48% |
| FY2020 | 1.8× | (85.07%) |
| FY2019 | 11.8× | 321.02% |
| FY2018 | 2.8× | (21.86%) |
| FY2017 | 3.6× | (32.22%) |
| FY2016 | 5.3× | 4.34% |
Quarterly newest first
| Period | Debt to equity | Change |
|---|---|---|
| Jun 2026 | 0.7× | (8.38%) |
| Mar 2026 | 0.7× | 16.19% |
| Dec 2025 | 0.6× | (14.55%) |
| Sep 2025 | 0.7× | (23.37%) |
| 42 more quarters | Free account |
Against its own ten years
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| GMED Globus Medical, Inc. compare | 0.0× |
| PEN Penumbra, Inc. compare | 0.0× |
| GKOS Glaukos Corporation compare | 0.1× |
| BIO Bio-Rad Laboratories, Inc. compare | 0.2× |
| BIO.B Bio-Rad Laboratories, Inc. compare | 0.2× |
| SNN Smith & Nephew SNATS, Inc. compare | 0.6× |
| PODD Insulet Corporation | 0.7× |
| BRKR Bruker Corporation compare | 0.8× |
| HAE Haemonetics Corporation compare | 1.4× |
| Medical Devices industry median | 0.1× |
| Healthcare sector median | 0.0× |
| Market median | 0.1× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on PODD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement